Literature DB >> 7462802

Secretion of very low density lipoproteins enriched in cholesteryl esters by cultured rat hepatocytes during simulation of intracellular cholesterol esterification.

C A Drevon, S C Engelhorn, D Steinberg.   

Abstract

Very low density lipoproteins, newly secreted by cultured rat hepatocytes into a serum-free medium, contain some cholesteryl esters although the percentage of total cholesterol in ester form is less than that in plasma very low density lipoproteins. When acyl CoA:cholesterol acyltransferase activity in hepatocytes was stimulated by the addition of 25-hydroxycholesterol (10 microgram/ml) or mevalonolactone (1 mM), the absolute amount of esterified cholesterol secreted in very low density lipoproteins increased significantly, but the amount of free cholesterol decreased or showed no change. Thus the percentage of very low density lipoprotein cholesterol in ester form increased, in some experiments to as much as 50% of the total. These results provide additional evidence that hepatic acyl CoA:cholesterol acyltransferase plays a role in the generation of some of the cholesteryl ester in newly-secreted lipoproteins. They further suggest that changes in the activity of the enzyme can potentially regulate the fraction of cholesterol secreted in esterified form.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7462802

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  12 in total

1.  Effect of SMP-500, a novel ACAT inhibitor, on hepatic cholesterol disposition in rats.

Authors:  Katsuhisa Ioriya; Takeshi Nishimura; Naohito Ohashi
Journal:  Lipids       Date:  2002-04       Impact factor: 1.880

2.  The effects of monensin on secretion of very-low-density lipoprotein and metabolism of asialofetuin by cultured rat hepatocytes.

Authors:  A C Rustan; J O Nossen; T Berg; C A Drevon
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

3.  Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat.

Authors:  F Nervi; I Marinović; A Rigotti; N Ulloa
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Evidence for phosphorylation/dephosphorylation of rat liver acyl-CoA:cholesterol acyltransferase.

Authors:  K L Gavey; D L Trujillo; T J Scallen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

5.  Dietary oxidized cholesterol modulates cholesterol metabolism and linoleic acid desaturation in rats fed high-cholesterol diets.

Authors:  K Osada; T Kodama; K Yamada; S Nakamura; M Sugano
Journal:  Lipids       Date:  1998-08       Impact factor: 1.880

6.  Very low density lipoprotein secretion by cultured hepatocytes of rabbits fed purified or autoxidized cholesterol.

Authors:  V A Kosykh; V Z Lankin; E A Podrez; D K Novikov; S A Volgushev; A V Victorov; V S Repin; V N Smirnov
Journal:  Lipids       Date:  1989-02       Impact factor: 1.880

7.  Retinol esterification in cultured rat liver cells.

Authors:  C A Drevon; R Blomhoff; M Rasmussen; G M Kindberg; T Berg; K R Norum
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

8.  Changes in both acyl-CoA:cholesterol acyltransferase activity and microsomal lipid composition in rat liver induced by distal-small-bowel resection.

Authors:  M T Molina; C M Vázquez; V Ruiz-Gutierrez
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

9.  Factors regulating the secretion of lysophosphatidylcholine by rat hepatocytes compared with the synthesis and secretion of phosphatidylcholine and triacylglycerol. Effects of albumin, cycloheximide, verapamil, EGTA and chlorpromazine.

Authors:  A Graham; A J Bennett; A A McLean; V A Zammit; D N Brindley
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

10.  Effects of bile salts on rat hepatic acyl CoA:cholesterol acyltransferase.

Authors:  S K Erickson; P E Van Zuiden
Journal:  Lipids       Date:  1995-10       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.